Gene · 1633
Papers2,658
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,658
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Involvement of Long Non-Coding RNAs in Glutamine-Metabolic Reprogramming and Therapeutic Resistance in Cancer. | Int J Mol Sci | 2022 | 36499136 | PubTator, text mining | PubMed |
| Integrative proteomics and m6A microarray analyses of the signatures induced by METTL3 reveals prognostically significant in gastric cancer by affecting cellular metabolism. | Front Oncol | 2022 | 36465351 | PubTator, text mining | PubMed |
| Editorial: How pharmacogenomics, epigenetics, and data analysis could improve anticancer treatment? | Front Pharmacol | 2022 | 36438848 | PubTator, text mining | PubMed |
| Mass cytometry reveals cladribine-induced resets among innate lymphoid cells in multiple sclerosis. | Sci Rep | 2022 | 36437270 | PubTator, text mining | PubMed |
| Molecular and spatial heterogeneity of microglia in Rasmussen encephalitis. | Acta Neuropathol Commun | 2022 | 36411471 | PubTator, text mining | PubMed |
| Integrated analysis of transcriptomics, proteomics and metabolomics data reveals the role of SLC39A1 in renal cell carcinoma. | Front Cell Dev Biol | 2022 | 36407113 | PubTator, text mining | PubMed |
| Highly effective identification of drug targets at the proteome level by pH-dependent protein precipitation. | Chem Sci | 2022 | 36382280 | PubTator, text mining | PubMed |
| Cladribine treatment improves cortical network functionality in a mouse model of autoimmune encephalomyelitis. | J Neuroinflammation | 2022 | 36348455 | PubTator, text mining | PubMed |
| Computational simulation and target prediction studies of solubility optimization of decitabine through supercritical solvent. | Sci Rep | 2022 | 36344531 | PubTator, text mining | PubMed |
| Comprehensive analysis of lncRNA-mediated ceRNA networkfor hepatocellular carcinoma. | Front Oncol | 2022 | 36338699 | PubTator, text mining | PubMed |
| The genetics of myelodysplastic syndromes and the opportunities for tailored treatments. | Front Oncol | 2022 | 36338673 | PubTator, text mining | PubMed |
| Niraparib-induced STAT3 inhibition increases its antitumor effects. | Front Oncol | 2022 | 36324587 | PubTator, text mining | PubMed |
| Design of amino acid- and carbohydrate-based anticancer drugs to inhibit polymerase η. | Sci Rep | 2022 | 36323739 | PubTator, text mining | PubMed |
| EZH2: Its regulation and roles in immune disturbance of SLE. | Front Pharmacol | 2022 | 36313363 | PubTator, text mining | PubMed |
| Evaluation of cross-platform compatibility of a DNA methylation-based glucocorticoid response biomarker. | Clin Epigenetics | 2022 | 36307860 | PubTator, text mining | PubMed |
| Culprits of PDAC resistance to gemcitabine and immune checkpoint inhibitor: Tumour microenvironment components. | Front Mol Biosci | 2022 | 36299300 | PubTator, text mining | PubMed |
| Positron Emission Tomography Probes for Imaging Cytotoxic Immune Cells. | Pharmaceutics | 2022 | 36297474 | PubTator, text mining | PubMed |
| Impact of Genetic Polymorphisms and Biomarkers on the Effectiveness and Toxicity of Treatment of Chronic Myeloid Leukemia and Acute Myeloid Leukemia. | J Pers Med | 2022 | 36294746 | PubTator, text mining | PubMed |
| Identification and Analysis of Immune-Related Gene Signature in Hepatocellular Carcinoma. | Genes (Basel) | 2022 | 36292719 | PubTator, text mining | PubMed |
| Decitabine-induced DNA methylation-mediated transcriptomic reprogramming in human breast cancer cell lines; the impact of DCK overexpression. | Front Pharmacol | 2022 | 36278182 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1633/papers?page=13